Gilead Sciences to Acquire Tubulis to Advance Targeted Cancer Therapies - The Healthcare Technology Report.
Gilead Sciences→Tubulis
May 4, 2026
Track acquisitions, mergers, and investments in the healthcare sector.
Tentt has tracked 666 healthcare M&A deals, with 225 transactions recorded in the last 30 days. The most active sub-sectors include Healthcare Services Other (163), Pharmacy (135), Medical Devices (106), Healthcare It (40).
California leads with 55 deals, followed by New York and Florida. Strategic accounts for 68% of buyer activity in this sector, with Private Equity (145), Public Company (27) also active.
The most recent transaction tracked is "Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18."
Gilead Sciences→Tubulis
May 4, 2026
UCB→Candid Therapeutics
May 4, 2026
UCB→Candid Therapeutics
May 4, 2026
Addus HomeCare→HomeCourt Home Care
May 4, 2026
UCB→Candid Therapeutics
May 3, 2026
Pennant→Senior Living Communities
May 1, 2026
PharmaCorp Rx
May 1, 2026
Legacy Therapeutics→Cansortium Texas
May 1, 2026
Avalyn Pharma
May 1, 2026
Vineyard Park Senior Living→Truewood First Hill
May 1, 2026
Monument Health→Rapid City Medical Center
May 1, 2026
Black Pearl Equities→Selectis Health
May 1, 2026
ArchiMed→Esperion Therapeutics
May 1, 2026
Artemis→Optikos
May 1, 2026
Spring Health→Alma
May 1, 2026
Nova Leap Health→Parkwood Home Care
May 1, 2026
Sun Pharma→Organon
May 1, 2026
Vireo Growth→Fluent
May 1, 2026
United Surgical Partners International→ASCs (seven acquired)
Apr 30, 2026
Volaris Group→Interplayers
Apr 30, 2026